Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124764909> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2124764909 endingPage "2017" @default.
- W2124764909 startingPage "2013" @default.
- W2124764909 abstract "Background. The treatment of frequently relapsing (FR) and steroid‐dependent (SD) idiopathic nephrotic syndrome (INS) with oral cyclophosphamide (OCP) poses problems of compliance, side‐effects and infections. Methods. We prospectively evaluated the usefulness of intravenous cyclophosphamide (IVCP) in children with steroid sensitive INS who were frequent relapsers or steroid dependent. Fifty‐one children were included in the study of whom 22 were FR and 29 were SD. IVCP was administered in a dose of 500 mg/m2/month for 6 months after achieving a steroid‐induced remission. The response to IVCP was evaluated in terms of remission, change in the steroid response status of the patient, duration of remission (i.e. proteinuria‐free days), side effects and compliance with therapy. Results. The proteinuria‐free days (mean 19.9±3.5 before IVCP therapy vs 1256±167 days after IVCP therapy) (P<0.00001), and serum albumin levels (23±1.6 g/l before IVCP therapy vs 34±2 g/l after IVCP therapy) (P<0.001) were significantly higher following IVCP therapy. The cumulative remission rate in the study group was 49% at 5 years and was comparable to that achieved with oral cyclophosphamide at a 40% lower cumulative dose. Conclusions. We conclude that IVCP is a safe and effective therapeutic modality in children with INS who are FR and SD. Its efficacy is comparable to the results obtained with oral cyclophosphamide based on historical comparisons with previous studies." @default.
- W2124764909 created "2016-06-24" @default.
- W2124764909 creator A5037155360 @default.
- W2124764909 creator A5044163443 @default.
- W2124764909 creator A5046122094 @default.
- W2124764909 creator A5050171498 @default.
- W2124764909 creator A5058405202 @default.
- W2124764909 creator A5071464253 @default.
- W2124764909 creator A5089507477 @default.
- W2124764909 date "2001-10-01" @default.
- W2124764909 modified "2023-10-14" @default.
- W2124764909 title "Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome" @default.
- W2124764909 cites W1966598584 @default.
- W2124764909 cites W1988018442 @default.
- W2124764909 cites W1992195172 @default.
- W2124764909 cites W2011641474 @default.
- W2124764909 cites W2027272349 @default.
- W2124764909 cites W2041793698 @default.
- W2124764909 cites W2049683158 @default.
- W2124764909 cites W2070230496 @default.
- W2124764909 cites W2085903199 @default.
- W2124764909 cites W2101944817 @default.
- W2124764909 cites W2325870812 @default.
- W2124764909 cites W4238630369 @default.
- W2124764909 doi "https://doi.org/10.1093/ndt/16.10.2013" @default.
- W2124764909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11572890" @default.
- W2124764909 hasPublicationYear "2001" @default.
- W2124764909 type Work @default.
- W2124764909 sameAs 2124764909 @default.
- W2124764909 citedByCount "34" @default.
- W2124764909 countsByYear W21247649092014 @default.
- W2124764909 countsByYear W21247649092015 @default.
- W2124764909 countsByYear W21247649092016 @default.
- W2124764909 countsByYear W21247649092017 @default.
- W2124764909 countsByYear W21247649092019 @default.
- W2124764909 countsByYear W21247649092020 @default.
- W2124764909 crossrefType "journal-article" @default.
- W2124764909 hasAuthorship W2124764909A5037155360 @default.
- W2124764909 hasAuthorship W2124764909A5044163443 @default.
- W2124764909 hasAuthorship W2124764909A5046122094 @default.
- W2124764909 hasAuthorship W2124764909A5050171498 @default.
- W2124764909 hasAuthorship W2124764909A5058405202 @default.
- W2124764909 hasAuthorship W2124764909A5071464253 @default.
- W2124764909 hasAuthorship W2124764909A5089507477 @default.
- W2124764909 hasConcept C126322002 @default.
- W2124764909 hasConcept C141071460 @default.
- W2124764909 hasConcept C151032500 @default.
- W2124764909 hasConcept C2776694085 @default.
- W2124764909 hasConcept C2776755627 @default.
- W2124764909 hasConcept C2778930706 @default.
- W2124764909 hasConcept C2779561371 @default.
- W2124764909 hasConcept C2780091579 @default.
- W2124764909 hasConcept C71924100 @default.
- W2124764909 hasConcept C90924648 @default.
- W2124764909 hasConceptScore W2124764909C126322002 @default.
- W2124764909 hasConceptScore W2124764909C141071460 @default.
- W2124764909 hasConceptScore W2124764909C151032500 @default.
- W2124764909 hasConceptScore W2124764909C2776694085 @default.
- W2124764909 hasConceptScore W2124764909C2776755627 @default.
- W2124764909 hasConceptScore W2124764909C2778930706 @default.
- W2124764909 hasConceptScore W2124764909C2779561371 @default.
- W2124764909 hasConceptScore W2124764909C2780091579 @default.
- W2124764909 hasConceptScore W2124764909C71924100 @default.
- W2124764909 hasConceptScore W2124764909C90924648 @default.
- W2124764909 hasIssue "10" @default.
- W2124764909 hasLocation W21247649091 @default.
- W2124764909 hasLocation W21247649092 @default.
- W2124764909 hasOpenAccess W2124764909 @default.
- W2124764909 hasPrimaryLocation W21247649091 @default.
- W2124764909 hasRelatedWork W198824877 @default.
- W2124764909 hasRelatedWork W2158287250 @default.
- W2124764909 hasRelatedWork W2353153605 @default.
- W2124764909 hasRelatedWork W2371727475 @default.
- W2124764909 hasRelatedWork W2372234355 @default.
- W2124764909 hasRelatedWork W2397846374 @default.
- W2124764909 hasRelatedWork W2398998059 @default.
- W2124764909 hasRelatedWork W2405610365 @default.
- W2124764909 hasRelatedWork W2407405571 @default.
- W2124764909 hasRelatedWork W2411938410 @default.
- W2124764909 hasVolume "16" @default.
- W2124764909 isParatext "false" @default.
- W2124764909 isRetracted "false" @default.
- W2124764909 magId "2124764909" @default.
- W2124764909 workType "article" @default.